Showing results (121-130 of 594) with videos related to
Sort By:
Pageof 60
Bioorganic & Medicinal Chemistry Letters|November 7, 2006
Antiviral 2,5-disubstituted imidazo[4,5-c]pyridines: from anti-pestivirus to anti-hepatitis C virus activityGerhard Puerstinger, Jan Paeshuyse, Erik De Clercq, et al.Antiviral Research|November 14, 2006
Ribavirin and mycophenolic acid markedly potentiate the anti-hepatitis B virus activity of entecavirChunxiao Ying, Richard Colonno, Erik De Clercq, et al.The Journal of Antimicrobial Chemotherapy|June 22, 2014
Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviralLeen Delang, Nidya Segura Guerrero, Ali Tas, et al.Journal of Medicinal Chemistry|January 16, 2025
Structure-Based Optimization of Pyridone α-Ketoamides as Inhibitors of the SARS-CoV-2 Main ProteaseRavi Kumar Akula, Haifa El Kilani, Alina Metzen, et al.Nature Communications|February 16, 2022
The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concernRana Abdelnabi, Caroline S Foo, Dirk Jochmans, et al.Antimicrobial Agents and Chemotherapy|June 10, 2015
The enterovirus 3C protease inhibitor SG85 efficiently blocks rhinovirus replication and is not cross-resistant with rupintrivirCéline Lacroix, Shyla George, Pieter Leyssen, et al.Antiviral Chemistry & Chemotherapy|September 16, 2021
Assessment of the anti-norovirus activity in cell culture using the mouse norovirus: Early mechanistic studiesJana Van Dycke, Jasper Rymenants, Johan Neyts, et al.Molecules (Basel, Switzerland)|March 26, 2014
Trigocherrierin A, a potent inhibitor of chikungunya virus replicationMélanie Bourjot, Pieter Leyssen, Johan Neyts, et al.Antiviral Research|August 30, 2011
The main hepatitis B virus (HBV) mutants resistant to nucleoside analogs are susceptible in vitro to non-nucleoside inhibitors of HBV replicationGaëtan Billioud, Christian Pichoud, Gerhard Puerstinger, et al.Journal of Virological Methods|February 8, 2011
Diagnostic performance and application of two commercial cell viability assays in foot-and-mouth disease researchTom Willems, David J Lefebvre, Johan Neyts, et al.Pageof 60